XBI
- SPDR S&P Biotech ETFInformazioni chiave
| Data più antica | 2006-02-06 |
Informazioni ETF
| Emittente del fondo | State Street |
| Indice | S&P Biotechnology Select Industry |
| Commissione di gestione | 0.35% |
| Numero di titoli in portafoglio | 140 |
| Data di lancio | 2006-01-31 |
| Classe di asset | Equity |
| Quotazione | US-listed |
| Settore | Healthcare |
| Stile di investimento | Growth |
| Senza leva finanziaria | Non-leveraged |
Informazioni su XBI
The SPDR S&P Biotech ETF (XBI) provides exposure to the biotechnology sector in the United States, offering a diversified portfolio of mid-cap and small-cap securities. The fund tracks the S&P Biotechnology Select Industry Index, using an equal-weighted methodology to balance assets across all components. This ETF is suitable for investors seeking to fine-tune their exposure to the health care sector or those bullish on biotechnology over the long run.